Nontuberculous mycobacteria among patients who are suspected for multidrug-resistant tuberculosis-need for earlier identification of nontuberculosis mycobacteria.
Détails
ID Serval
serval:BIB_3FF27A45F76F
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Nontuberculous mycobacteria among patients who are suspected for multidrug-resistant tuberculosis-need for earlier identification of nontuberculosis mycobacteria.
Périodique
The American journal of the medical sciences
ISSN
0002-9629 (Print)
ISSN-L
0002-9629
Statut éditorial
Publié
Date de publication
03/2009
Peer-reviewed
Oui
Volume
337
Numéro
3
Pages
182-184
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: ppublish
Publication Status: ppublish
Résumé
In this study, we intended to find the prevalence of nontuberculosis mycobacteria (NTM) among patients who are referred as suspected multidrug-resistant tuberculosis (MDR-TB) cases to the only referral center in Iran.
All patients referred to our center in 2002-2006 as MDR-TB with histories of treatment with standard and CAT II World Health Organization regimens were included in the study. Sputum smear and culture for acid-fast bacilli were performed for all patients 3 times. Sputum polymerase chain reaction was also performed for all patients. Mycobacterial identification was performed via polymerase chain reaction and routine identification tests for all culture-positive cases.
Of the 105 patients in the study, 12 (11.43%) were identified to have NTM infection. The identified mycobacteria were classified in order of prevalence as Chelonae (8 cases), Simiae (2 cases), Aloei (1 case), and Farcinogen (1 case). Based on radiologic findings, most of the cases demonstrated bilateral nodularity (83.3%) and also multifocal bronchiectasis (75%). Notably, cavitary lesions were present in 41.7% of the cases.
Based on the findings of this study, it is essential that such cases be identified before commencing MDR-TB treatment.
All patients referred to our center in 2002-2006 as MDR-TB with histories of treatment with standard and CAT II World Health Organization regimens were included in the study. Sputum smear and culture for acid-fast bacilli were performed for all patients 3 times. Sputum polymerase chain reaction was also performed for all patients. Mycobacterial identification was performed via polymerase chain reaction and routine identification tests for all culture-positive cases.
Of the 105 patients in the study, 12 (11.43%) were identified to have NTM infection. The identified mycobacteria were classified in order of prevalence as Chelonae (8 cases), Simiae (2 cases), Aloei (1 case), and Farcinogen (1 case). Based on radiologic findings, most of the cases demonstrated bilateral nodularity (83.3%) and also multifocal bronchiectasis (75%). Notably, cavitary lesions were present in 41.7% of the cases.
Based on the findings of this study, it is essential that such cases be identified before commencing MDR-TB treatment.
Mots-clé
Adult, Aged, Female, Humans, Male, Middle Aged, Mycobacterium/isolation & purification, Polymerase Chain Reaction, Tuberculosis, Multidrug-Resistant/microbiology
Pubmed
Web of science
Création de la notice
04/02/2021 20:02
Dernière modification de la notice
07/07/2021 6:37
Données d'usage
